Gene · 1948
Papers2,853
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 2,853
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Tongxinluo promotes endothelium-dependent arteriogenesis to attenuate diabetic peripheral arterial disease. | World J Diabetes | 2023 | 37035233 | PubTator, text mining | PubMed |
| Cellular heterogeneity and stem cells of vascular endothelial cells in blood vessel formation and homeostasis: Insights from single-cell RNA sequencing. | Front Cell Dev Biol | 2023 | 37025170 | PubTator, text mining | PubMed |
| Oncogenic signaling is coupled to colorectal cancer cell differentiation state. | J Cell Biol | 2023 | 37017636 | PubTator, text mining | PubMed |
| Exosomes Derived from Human Umbilical Cord Mesenchymal Stem Cells Enhance Angiogenesis Through Upregulation of the VWF and Flk1 Genes in Endothelial Cells. | Adv Exp Med Biol | 2023 | 37014542 | PubTator, text mining | PubMed |
| Salmonella enhances osteogenic differentiation in adipose-derived mesenchymal stem cells. | Front Cell Dev Biol | 2023 | 37009487 | PubTator, text mining | PubMed |
| A key driver to promote HCC: Cellular crosstalk in tumor microenvironment. | Front Oncol | 2023 | 37007125 | PubTator, text mining | PubMed |
| Quantitative Proteomics for the Identification of Differentially Expressed Proteins in the Extracellular Vesicles of Cervical Cancer Cells. | Viruses | 2023 | 36992411 | PubTator, text mining | PubMed |
| Host-Pathogen Interactions Influencing Zoonotic Spillover Potential and Transmission in Humans. | Viruses | 2023 | 36992308 | PubTator, text mining | PubMed |
| Knockdown SENP1 Suppressed the Angiogenic Potential of Mesenchymal Stem Cells by Impacting CXCR4-Regulated MRTF-A SUMOylation and CCN1 Expression. | Biomedicines | 2023 | 36979893 | PubTator, text mining | PubMed |
| Anti-angiogenic therapy in ovarian cancer: Current understandings and prospects of precision medicine. | Front Pharmacol | 2023 | 36959862 | PubTator, text mining | PubMed |
| Notch Signaling-Modified Mesenchymal Stem Cell Patch Improves Left Ventricular Function via Arteriogenesis Induction in a Rat Myocardial Infarction Model. | Cell Transplant | 2023 | 36946544 | PubTator, text mining | PubMed |
| Neuronal guidance genes in health and diseases. | Protein Cell | 2023 | 36942388 | PubTator, text mining | PubMed |
| Shaping the brain vasculature in development and disease in the single-cell era. | Nat Rev Neurosci | 2023 | 36941369 | PubTator, text mining | PubMed |
| Emerging trends and research foci of berberine on tumor from 2002 to 2021: A bibliometric article of the literature from WoSCC. | Front Pharmacol | 2023 | 36937842 | PubTator, text mining | PubMed |
| Oscillatory shear stress modulates Notch-mediated endothelial mesenchymal plasticity in cerebral arteriovenous malformations. | Cell Mol Biol Lett | 2023 | 36934253 | PubTator, text mining | PubMed |
| Single-Cell RNA Sequencing Unifies Developmental Programs of Esophageal and Gastric Intestinal Metaplasia. | Cancer Discov | 2023 | 36929873 | PubTator, text mining | PubMed |
| The roles of bone remodeling in normal hematopoiesis and age-related hematological malignancies. | Bone Res | 2023 | 36918531 | PubTator, text mining | PubMed |
| A Brief Review on Chemoresistance; Targeting Cancer Stem Cells as an Alternative Approach. | Int J Mol Sci | 2023 | 36901917 | PubTator, text mining | PubMed |
| Targeting p53 pathways: mechanisms, structures, and advances in therapy. | Signal Transduct Target Ther | 2023 | 36859359 | PubTator, text mining | PubMed |
| Blood-Brain Barrier Dysfunction in Normal Aging and Neurodegeneration: Mechanisms, Impact, and Treatments. | Stroke | 2023 | 36848419 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1948/papers?page=18